Five Prime Therapeutics (FPRX) PT Lowered to $25 at Nomura/Instinet
Tweet Send to a Friend
Nomura/Instinet lowered its price target on Five Prime Therapeutics (NASDAQ: FPRX) to $25.00 (from $94.00) while maintaining a Buy rating.Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
